Literature DB >> 3202421

Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium.

N A Flavahan1, N R Slifman, G J Gleich, P M Vanhoutte.   

Abstract

Major basic protein (MBP), one of several cationic proteins associated with the eosinophil granule, is cytotoxic to respiratory epithelium and is present in the sputum of asthmatics and on damaged bronchial epithelium from patients dying of asthma. The present experiments were performed in order to determine the effects of MBP on the responsiveness of airway smooth muscle. Rings of guinea pig trachea, in some of which the epithelium had been gently removed by rubbing, were incubated for 5 h in modified Krebs-Ringer bicarbonate solution containing buffer or human MBP (100 micrograms/ml). The tracheal rings were then suspended for isometric tension recording in organ chambers filled with Krebs-Ringer solution containing indomethacin. MBP did not affect the reactivity of rings in which the epithelium had been removed, but significantly augmented that of unrubbed rings to acetylcholine and histamine. The results suggest that MBP, by inhibiting the function of epithelial but not smooth muscle cells, causes hyperreactivity of respiratory smooth muscle, which may contribute to the hyperreactivity observed in chronic respiratory disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202421     DOI: 10.1164/ajrccm/138.3.685

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  42 in total

Review 1.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Update on reslizumab for eosinophilic asthma.

Authors:  Juan Carlos Cardet; Elliot Israel
Journal:  Expert Opin Biol Ther       Date:  2015       Impact factor: 4.388

3.  Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study.

Authors:  J de Boer; H Meurs; W Coers; M Koopal; A E Bottone; A C Visser; W Timens; J Zaagsma
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Role of airway eosinophilia and eosinophil activation in Sephadex-induced inflammation.

Authors:  Karim Maghni; François Nantel; Chantal Lanoue; Solange Cloutier; Jean-Paul Cristol; Alain Cadieux; Pierre Sirois
Journal:  Inflammation       Date:  2004-08       Impact factor: 4.092

Review 5.  The future of asthma therapy: integrating clinical and experimental studies.

Authors:  David B Corry; Farrah Kheradmand
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 6.  Animal models for testing anti-inflammatory drugs for treatment of bronchial hyperreactivity in asthma.

Authors:  M J Linssen; O H Wilhelms; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1991-12-13

7.  In vitro modulation of the eosinophil-dependent enhancement of the permeability of the bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

8.  Multiple antigen challenge produces pulmonary eosinophilia but not pulmonary hyperresponsiveness in actively sensitized guinea pigs.

Authors:  J W Watson; V L Cohan; A K Shay; K W Freiert
Journal:  Agents Actions       Date:  1992-11

Review 9.  Promise and pitfalls in animal-based asthma research: building a better mousetrap.

Authors:  David B Corry; Charles G Irvin
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

10.  Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding.

Authors:  Seema Aceves; Ikuo Hirano; Glenn T Furuta; Margaret H Collins
Journal:  Semin Immunopathol       Date:  2012-07-29       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.